ARKG: ARK Genomic Revolution ETF - MutualFunds.com
Continue to site >
Trending ETFs

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

ARK Genomic Revolution ETF

ARKG - Snapshot

Vitals

  • YTD Return -7.1%
  • 3 Yr Annualized Return 43.8%
  • 5 Yr Annualized Return 37.4%
  • Net Assets $8.29 B
  • Holdings in Top 10 43.1%

52 WEEK LOW AND HIGH

N/A
N/A
N/A

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.75%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 64.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) N/A
  • IRA N/A

Fund Classification


Compare ARKG to Popular Health Care Sector Equity Funds and ETFs

Overview

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

$233.38

-0.48%

$49.75 B

0.92%

$2.16

8.19%

0.32%

$125.17

+0.77%

$27.65 B

1.37%

$1.70

10.34%

0.13%

$106.04

+1.00%

$18.04 B

-

$0.00

7.27%

0.76%

$121.36

-0.36%

$17.26 B

1.19%

$1.45

8.44%

0.10%

$244.77

+0.85%

$17.26 B

1.20%

$2.90

9.40%

0.10%

ARKG - Profile

Distributions

  • YTD Total Return -6.5%
  • 3 Yr Annualized Total Return 43.8%
  • 5 Yr Annualized Total Return 37.4%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.73%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    ARK Genomic Revolution ETF
  • Fund Family Name
    ARK ETF Trust
  • Inception Date
    Oct 30, 2014
  • Shares Outstanding
    101500758
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Catherine Wood

Fund Description

The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.


ARKG - Performance

Return Ranking - Trailing

Period ARKG Return Category Return Low Category Return High Rank in Category (%)
YTD -7.1% -12.5% 23.0% 96.51%
1 Yr 78.1% -1.4% 110.6% 1.19%
3 Yr 43.8%* 3.2% 43.8% 0.68%
5 Yr 37.4%* 3.7% 37.4% 0.71%
10 Yr N/A* 8.4% 18.8% N/A

* Annualized

Return Ranking - Calendar

Period ARKG Return Category Return Low Category Return High Rank in Category (%)
2020 178.2% -13.6% 178.2% 0.62%
2019 39.8% 3.8% 63.8% 4.83%
2018 -2.1% -49.7% 21.5% 30.66%
2017 44.7% -59.8% 54.4% 2.22%
2016 -19.2% -36.6% 11.6% 67.19%

Total Return Ranking - Trailing

Period ARKG Return Category Return Low Category Return High Rank in Category (%)
YTD -6.5% -12.5% 23.0% 97.09%
1 Yr 78.1% -1.4% 110.6% 1.19%
3 Yr 43.8%* 3.2% 43.8% 0.68%
5 Yr 37.4%* 3.7% 37.4% 0.71%
10 Yr N/A* 8.4% 18.8% N/A

* Annualized

Total Return Ranking - Calendar

Period ARKG Return Category Return Low Category Return High Rank in Category (%)
2020 178.2% -13.6% 178.2% 0.62%
2019 39.8% 3.8% 63.8% 4.83%
2018 -2.1% -25.3% 22.2% 40.88%
2017 44.7% -10.8% 54.4% 4.44%
2016 -19.2% -36.6% 11.6% 77.34%

ARKG - Holdings

Concentration Analysis

ARKG Category Low Category High ARKG % Rank
Net Assets 8.29 B 6.68 M 49.7 B 9.83%
Number of Holdings 62 25 506 82.66%
Net Assets in Top 10 3.58 B 1.53 M 19.3 B 10.40%
Weighting of Top 10 43.06% 8.9% 78.2% 27.75%

Top 10 Holdings

  1. Arcturus Therapeutics Holdings Inc 8.32%
  2. Teladoc Health Inc 7.04%
  3. Illumina Inc 5.43%
  4. Compugen Ltd 5.14%
  5. Compugen Ltd 5.14%
  6. Compugen Ltd 5.14%
  7. Compugen Ltd 5.14%
  8. Compugen Ltd 5.14%
  9. Compugen Ltd 5.14%
  10. Compugen Ltd 5.14%

Asset Allocation

Weighting Return Low Return High ARKG % Rank
Stocks
99.67% 82.66% 105.23% 30.64%
Cash
0.33% -0.13% 17.34% 63.01%
Preferred Stocks
0.00% 0.00% 5.58% 45.66%
Other
0.00% -26.63% 8.98% 55.49%
Convertible Bonds
0.00% 0.00% 0.02% 39.31%
Bonds
0.00% 0.00% 18.37% 41.62%

Stock Sector Breakdown

Weighting Return Low Return High ARKG % Rank
Healthcare
95.77% 63.71% 100.00% 91.91%
Technology
2.34% 0.00% 19.82% 5.20%
Financial Services
1.04% 0.00% 3.21% 8.09%
Consumer Defense
0.43% 0.00% 29.47% 1.73%
Basic Materials
0.41% 0.00% 3.68% 26.59%
Utilities
0.00% 0.00% 0.00% 38.73%
Real Estate
0.00% 0.00% 6.18% 45.09%
Industrials
0.00% 0.00% 6.41% 47.98%
Energy
0.00% 0.00% 0.00% 38.73%
Communication Services
0.00% 0.00% 8.10% 42.20%
Consumer Cyclical
0.00% 0.00% 14.16% 43.93%

Stock Geographic Breakdown

Weighting Return Low Return High ARKG % Rank
US
85.24% 58.55% 101.51% 49.13%
Non US
14.43% 0.00% 40.32% 45.66%

ARKG - Expenses

Operational Fees

ARKG Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.75% 0.08% 7.05% 69.23%
Management Fee 0.75% 0.00% 1.25% 62.86%
12b-1 Fee 0.00% 0.00% 1.00% 6.58%
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

ARKG Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

ARKG Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

ARKG Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 64.00% 3.00% 256.00% 70.99%

ARKG - Distributions

Dividend Yield Analysis

ARKG Category Low Category High ARKG % Rank
Dividend Yield 0.00% 0.00% 0.95% 47.43%

Dividend Distribution Analysis

ARKG Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Annually Annually

Net Income Ratio Analysis

ARKG Category Low Category High ARKG % Rank
Net Income Ratio -0.73% -2.54% 1.74% 87.65%

Capital Gain Distribution Analysis

ARKG Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

ARKG - Fund Manager Analysis

Managers

Catherine Wood


Start Date

Tenure

Tenure Rank

Oct 30, 2014

6.59

6.6%

Cathie registered ARK Investment Management LLC (“ARK”) as an investment adviser with the U.S. Securities and Exchange Commission in January 2014. Prior to ARK, Cathie spent twelve years at AllianceBernstein as Chief Investment Officer of Global Thematic Strategies where she managed $5 billion. Cathie joined Alliance Capital from Tupelo Capital Management, a hedge fund she co-founded which, in 2000, managed $800 million in global thematic strategies. Prior to her tenure at Tupelo Capital, she worked for 18 years with Jennison Associates as Chief Economist, Equity Research Analyst, Portfolio Manager and Director. She started her career in Los Angeles, California at The Capital Group as an Assistant Economist. Cathie received her Bachelor of Science, summa cum laude, in Finance and Economics from the University of Southern California in 1981. In 2016, Cathie received the “Women in Finance – Outstanding Contribution Award” from Market Media.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.04 23.72 7.22 21.1